Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1655-1661

  Foster, Meika ^a   Petocz, Peter ^b   Samman, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Gene expression; Inflammation; Randomized controlled trial; Type 2 diabetes mellitus; Zinc transporter

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; INTERLEUKIN 6; LINOLENIC ACID; MESSENGER RNA; METALLOTHIONEIN; PLACEBO; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP1 PROTEIN; ZIP10 PROTEIN; ZIP3 PROTEIN; ZIP7 PROTEIN; ZNT5 PROTEIN; ZNT7 PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ZINC BLOOD LEVEL;

EID: 84881555167     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.02.006     Document Type: Article

References (49)

1. Foster M., Samman S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal 2010, 13:1549-1573. 10.1089/ars.2010.3111.
2. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.
3. Donath M.Y., Størling J., Maedler K., Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 2003, 81:455-470.
4. Spranger J., Kroke A., Möhlig M., Hoffman K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52:812-817.
5. Sun Q., van Dam R.M., Willet W.C., Hu F.B. Prospective study of zinc intake and risk of type 2 diabetes in women. Diabetes Care 2009, 32:629-634.
6. Ibs K.H., Rink L. Zinc-altered immune function. J Nutr 2003, 133:1452S-1456S.
7. Besecker B.Y., Exline M.C., Hollyfield J., Phillips G., Disilvestro R.A., Wewers M.D., Knoell D.L. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr 2011, 93:1356-1364.
8. Egefjord L., Jensen J.L., Bang-Berthelsen C.H., Petersen A.B., Smidt K., Schmitz O., et al. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?. BMC Endocr Disord 2009, 9:7. 10.1186/1472-6823-9-7.
9. Lang C., Murgia C., Leong M., Tan L.W., Perozzi G., Knight D., et al. Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol 2007, 292:L577-L584.
10. Liuzzi J.P., Lichten L.A., Rivera S., Blanchard R.K., Aydemir T.B., Knutson M.D., et al. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA 2005, 102:6843-6848.
11. Cousins R.J., Leinart A.S. Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J 1988, 2:2884-2890.
12. De S.K., McMaster M.T., Andrews G.K. Endotoxin induction of murine metallothionein gene expression. J Biol Chem 1990, 265:15267-15274.
13. Fukada T., Yamasaki S., Nishida K., Murakami M., Hirano T. Zinc homeostasis and signaling in health and diseases: zinc signaling. J Biol Inorg Chem 2011, 16:1123-1134.
14. Bao B., Prasad A.S., Beck F.W.J., Fitzgerald J.T., Snell D., Bao G.W., et al. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 2010, 91:1634-1641.
15. Prasad A.S., Bao B., Beck F.W.J., Kucuk O., Sarkar F.H. Antioxidant effect of zinc in humans. Free Rad Biol Med 2004, 37:1182-1190.
16. Prasad A.S., Beck F.W.J., Bao B., Fitzgerald J.T., Snell D.C., Steinberg J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007, 85:837-844.
17. Bao B., Prasad A.S., Beck F.W.J., Snell D., Suneja A., Sarkar F.H., et al. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res 2008, 152:67-80.
18. Aydemir T.B., Blanchard R.K., Cousins R.J. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci USA 2006, 103:1699-1704.
19. Kahmann L., Uciechowski P., Warmuth S., Plümäkers B., Gressner A.M., Malavolta M., et al. Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 2008, 11:227-237.
20. Sandstead H.H., Prasad A.S., Penland J.G., Beck F.W.J., Kaplan J., Egger N.G., et al. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins. Am J Clin Nutr 2008, 88:1067-1073.
21. Farzaneh-Far R., Harris W.S., Garg S., Na B., Whooley M.A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205:538-543.
22. Ferrucci L., Cherubini A., Bandinelli S., Bartali B., Corsi A., Lauretani F., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006, 91:439-446.
23. Satoh N., Shimatsu A., Kotani K., Sakane N., Yamada K., Suganami T., et al. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 2007, 30:144-146.
24. Browning L.M., Krebs J.D., Moore C.S., Mishra G.D., O'Connell M.A., Jebb S.A. The impact of long chain n-3 polyunsaturatedfatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007, 9:70-80.
25. Zhao G., Etherton T.D., Martin K.R., Gillies P.J., West S.G., Kris-Etherton P.M. Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am J Clin Nutr 2007, 85:385-391.
26. Zhao G., Etherton T.D., Martin K.R., West S.G., Gillies P.J., Kris-Etherton P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004, 134:2991-2997.
27. Lichten L.A., Cousins R.J. Mammalian zinc transporters: nutritional and physiological regulation. Annu Rev Nutr 2009, 29:153-176.
28. National Health and Medical Research Council (NHMRC) Nutrient reference values for Australia and New Zealand including recommended dietary intakes. Published by the Commonwealth of Australia 2006, [Canberra].
29. Foster M., Petocz P., Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis 2010, 210:344-352.
30. Samman S., Roberts D.C. The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms in healthy volunteers. Med J Aust 1987, 146:246-249.
31. Tran C.D., Miller L.V., Krebs N.F., Lei S., Hambidge K.M. Zinc absorption as a function of the dose of zinc sulfate in aqueous solution. Am J Clin Nutr 2004, 80:1570-1573.
32. Gibson R.S. Principles of nutritional assessment 2005, Oxford University Press, New York, [chapter 3]. 2nd ed.
33. Brown K.H., Rivera J.A., Bhutta Z., Gibson R.S., King J.C., Lonnerdal B., et al. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull 2004, 25(1 suppl 2):S99-S203.
34. Foster M., Hancock D., Petocz P., Samman S. Zinc transporter gene expression is co-ordinately expressed in men and women independently of dietary or plasma zinc. J Nutr 2011, 141:1195-1201.
35. Adams P.S. Data analysis and reporting. Real-time PCR (BIOS advanced methods) 2006, 39-62. Taylor and Francis Group, Oxford, UK. M.T. Dorak (Ed.).
36. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193.
37. Pfaffl M.W. Relative quantification. Real-time PCR (BIOS advanced methods) 2006, 63-82. Taylor and Francis Group, Oxford. M.T. Dorak (Ed.).
38. Foster M., Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients 2012, 4:676-694.
39. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., Mackey B.E. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009, 139:495-501.
40. Seet R.C., Lee C.Y., Lim E.C., Quek A.M., Huang H., Huang S.H., et al. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with type 2 diabetes with normal zinc levels. Atherosclerosis 2011, 219:231-239.
41. Mori T.A., Woodman R.J., Burke V., Puddey I.B., Croft K.D., Beilin L.J. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003, 35:772-781.
42. Dewell A., Marvasti F.F., Harris W.S., Tsao P., Gardner C.D. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr 2011, 141:2166-2171.
43. Wang F., Dufner-Beattie J., Kim B.E., Petris M.J., Andrews G., Eide D.J. Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters. J Biol Chem 2004, 279:24631-24639.
44. Zheng D., Feeney G.P., Kille P., Hogstrand C. Regulation of ZIP and ZnT zinc transporters in zebrafish gill: zinc repression of ZIP10 transcription by an intronic MRE cluster. Physiol Genomics 2008, 34:205-214.
45. Lichten L.A., Ryu M.-S., Guo L., Embury J., Cousins R.J. MTF-1-mediated repression of the zinc transporter Zip10 is alleviated by zinc restriction. PLoS One 2011, 6:e21526. 10.1371/journal.pone.0021526.
46. Huang L., Kirschke C.P., Zhang Y., Yu Y.Y. The ZIP7 gene (Slc39a7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus. J Biol Chem 2005, 280:15456-15463.
47. Sullivan V.K., Burnett F.R., Cousins R.J. Metallothionein expression is increased in monocytes and erythrocytes of young men during zinc supplementation. J Nutr 1998, 128:707-713.
48. Cao J., Cousins R.J. Metallothionein mRNA in monocytes and peripheral blood mononuclear cells and in cells from dried blood spots increases after zinc supplementation of men. J Nutr 2000, 130:2180-2187.
49. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus 1999, World Health Organisation, Geneva.